Mergers & Acquisitions
🇺🇸 FDA Page 6FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma M&A deals, divestitures, and partnerships. Gain critical intelligence for strategic investment and business development in life sciences.
Showing 61–72 of 73 articles
Merck-Kelun ADC's Strategic Wins and Takeda's Antitrust Loss
Incyte's Strategic AI Partnerships: Implications for Pharma
Parabilis IPO Plans Following Regeneron Deal: What You Need to Know
Bristol Myers Expands AI Capabilities with Anthropic Partnership
Supreme Court Decision on IRA Challenges: Implications for Pharma
Regeneron Secures $125M Parabilis Deal for Drug Targets
UCB Acquires Antibody Treatment Maker: Implications for Autoimmune Disease Market
Pfizer's Latest Developments: Insights for Investors and Executives
U.K. Advocacy Groups Challenge U.S. Pharma Trade Deal
Biopharma M&A Trends: Resilience Amidst Large Deal Decline
M&A Trends: Mid-Size Pharma Companies on the Rise
UCB Acquires Candid Therapeutics in Major Autoimmune Drug Development Deal